Protective effect of intranasal insulin on postoperative cognitive dysfunction in elderly patients with metabolic syndrome undergoing noncardiac surgery: a randomized clinical trial
CONCLUSIONS: Intranasal insulin administration reduced the incidence of POCD and alleviated peripheral inflammatory levels in elderly patients with metabolic syndrome.TRIAL REGISTRY: Chinese Clinical Trial Registry (ChiCTR1800015502).PMID:37993761 | DOI:10.1007/s40520-023-02593-7
Source: Aging Clinical and Experimental Research - Category: Geriatrics Authors: Yang Mi Ouyang Wen Long Ge Liu Xing Tong Jianbin Tang Yongzhong He Xi Source Type: research
More News: Brain | China Health | Clinical Trials | Geriatrics | Insulin | Metabolic Syndrome | Neurology | Neurosurgery | Study